At the same time, the fact that our trial consisted of metabolically healthy overweight people, who did not have diabetes or use statins, may have been in advantage in that we were able to investigate the mere effects of calorie restriction without potential confounding effects by drugs such as SGLT-2 inhibitors, which may affect kidney fat content [36]. This evidence concerns the gene SLC5A2 and diabetes mellitus.